Effect of estrogen on very low density lipoprotein and low density lipoprotein subclass metabolism in postmenopausal women.

PubWeight™: 1.88‹?› | Rank: Top 3%

🔗 View Article (PMID 9398695)

Published in J Clin Endocrinol Metab on December 01, 1997

Authors

H Campos1, B W Walsh, H Judge, F M Sacks

Author Affiliations

1: Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts 02115, USA. hphac@gauss.bwh.harvard.edu

Articles citing this

Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype. Circulation (2010) 1.67

Sex differences in lipid and lipoprotein metabolism: it's not just about sex hormones. J Clin Endocrinol Metab (2011) 1.55

Metabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteins. Arterioscler Thromb Vasc Biol (2009) 1.23

A longitudinal study of serum lipoproteins in relation to endogenous reproductive hormones during the menstrual cycle: findings from the BioCycle study. J Clin Endocrinol Metab (2010) 1.16

Multiple beneficial effects of estrogen on lipoprotein metabolism. J Clin Endocrinol Metab (1997) 0.90

Cardiovascular disease and menopause. J Clin Diagn Res (2014) 0.89

Gender-specific differences in the kinetics of nonfasting TRL, IDL, and LDL apolipoprotein B-100 in men and premenopausal women. Arterioscler Thromb Vasc Biol (2008) 0.88

Metabolism of apoB lipoproteins of intestinal and hepatic origin during constant feeding of small amounts of fat. J Lipid Res (2006) 0.88

Failure to consider the menstrual cycle phase may cause misinterpretation of clinical and research findings of cardiometabolic biomarkers in premenopausal women. Epidemiol Rev (2013) 0.84

Estrogen deficiency after menopause does not result in male very-low-density lipoprotein metabolism phenotype. J Clin Endocrinol Metab (2010) 0.83

Cardiovascular risk factors and menstrual cycle phase in pre-menopausal women. J Endocrinol Invest (2011) 0.78

The association of elective hormone therapy with changes in lipids among glucose intolerant postmenopausal women in the diabetes prevention program. Metabolism (2013) 0.76

Cholesteryl ester transfer protein alters liver and plasma triglyceride metabolism through two liver networks in female mice. J Lipid Res (2016) 0.76

Estrogen receptor alpha polymorphisms, estradiol level, and occurrence of atherosclerosis risk factors in healthy postmenopausal women. Med Sci Monit (2015) 0.75

Effects of gender and gonadectomy on growth and plasma cholesterol levels in pigs. Nutr Res Pract (2009) 0.75

Effect of Menstrual Cycle Phases on Plasma Lipid and Lipoprotein Levels in Regularly Menstruating Women. J Clin Diagn Res (2017) 0.75

Articles by these authors

A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med (1997) 19.93

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med (1991) 6.13

Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr (1999) 5.12

A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA (1996) 3.69

Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Ann Intern Med (2001) 3.56

Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators. Circulation (1999) 3.26

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation (1998) 3.19

Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial. Am J Clin Nutr (2001) 3.12

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators. Circulation (1998) 2.97

Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation (2005) 2.77

Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med (1991) 2.68

Prospective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Inst (1994) 2.68

Comparison of measures of fatty acid intake by subcutaneous fat aspirate, food frequency questionnaire, and diet records in a free-living population of US men. Am J Epidemiol (1992) 2.68

Comparison of the effects of oat bran and low-fiber wheat on serum lipoprotein levels and blood pressure. N Engl J Med (1990) 2.37

Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res (1999) 2.30

Randomised trial of fish oil for prevention of restenosis after coronary angioplasty. Lancet (1989) 2.28

The relation between dietary intake and adipose tissue composition of selected fatty acids in US women. Am J Clin Nutr (1998) 2.24

Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial. Ann Intern Med (1998) 2.22

Fatty acid composition of the subcutaneous adipose tissue and risk of proliferative benign breast disease and breast cancer. J Natl Cancer Inst (1993) 2.15

Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group. Ann Intern Med (1996) 2.03

Cardiovascular disease in women. Circulation (1993) 1.87

Fatty acid composition of subcutaneous adipose tissue and diet in postmenopausal US women. Am J Clin Nutr (1991) 1.78

Low-density lipoprotein size, pravastatin treatment, and coronary events. JAMA (2001) 1.75

A prospective study of egg consumption and risk of cardiovascular disease in men and women. JAMA (1999) 1.74

Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial. J Am Coll Cardiol (1998) 1.67

Thermal balloon and rollerball ablation to treat menorrhagia: a multicenter comparison. Obstet Gynecol (1998) 1.61

Plasma lipids and lipoproteins in vegetarians and controls. N Engl J Med (1975) 1.59

Effect of transport conditions on the stability of biochemical markers in blood. Clin Chem (1989) 1.58

Chewing the fat--how much and what kind? N Engl J Med (1991) 1.57

Beta-carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma. Cancer (1999) 1.50

Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med (1994) 1.48

The DASH Diet, Sodium Intake and Blood Pressure Trial (DASH-sodium): rationale and design. DASH-Sodium Collaborative Research Group. J Am Diet Assoc (1999) 1.40

Blood pressure in vegetarians. Am J Epidemiol (1974) 1.40

Is there anything to add to our lipid risk factors for coronary heart disease? Am J Cardiol (1995) 1.39

The effect of dietary patterns on blood pressure control in hypertensive patients: results from the Dietary Approaches to Stop Hypertension (DASH) trial. Am J Hypertens (2000) 1.39

Relation of vessel wall shear stress to atherosclerosis progression in human coronary arteries. Arterioscler Thromb (1993) 1.38

Dietary fiber and cardiovascular disease--direct protection or indicator of a healthy lifestyle? Am J Prev Med (1993) 1.38

Effect of dietary patterns on ambulatory blood pressure : results from the Dietary Approaches to Stop Hypertension (DASH) Trial. DASH Collaborative Research Group. Hypertension (1999) 1.14

Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women. Circulation (1998) 1.13

Ingestion of egg raises plasma low density lipoproteins in free-living subjects. Lancet (1984) 1.12

Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia. J Lipid Res (2001) 1.11

Dietary Approaches to Stop Hypertension: rationale, design, and methods. DASH Collaborative Research Group. J Am Diet Assoc (1999) 1.11

Estradiol with or without progesterone and ambulatory blood pressure in postmenopausal women. Hypertension (1999) 1.09

A prospective study of nutritional factors and hypertension among US women. Circulation (1989) 1.08

The association of dietary fat with serum cholesterol in vegetarians: the effect of dietary assessment on the correlation coefficient. Am J Epidemiol (1988) 1.03

Patterns of tumor initiation in choroidal melanoma. Cancer Res (2000) 1.02

Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study. J Hypertens (2001) 1.00

Relation of moderate alcohol consumption and risk of systemic hypertension in women. Am J Cardiol (1990) 0.99

Addition of alendronate to ongoing hormone replacement therapy in the treatment of osteoporosis: a randomized, controlled clinical trial. J Clin Endocrinol Metab (1999) 0.98

Implications of the ACCORD lipid study: perspective from the Residual Risk Reduction Initiative (R(3)i). Curr Med Res Opin (2010) 0.97

Effects of postmenopausal hormone replacement with oral and transdermal estrogen on high density lipoprotein metabolism. J Lipid Res (1994) 0.97

Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations. Cholesterol and Recurrent Events CARE Investigators. J Am Coll Cardiol (1999) 0.96

Effects of estrogenic oral contraceptives on the lipoprotein B particle system defined by apolipoproteins E and C-III content. J Lipid Res (1999) 0.96

Coagulation activation following estrogen administration to postmenopausal women. Thromb Haemost (1992) 0.96

Cost-effectiveness of pravastatin therapy for survivors of myocardial infarction with average cholesterol levels. Am Heart J (2001) 0.96

Lipid-lowering therapy in acute coronary syndromes. JAMA (2001) 0.94

A 12-month comparative study of raloxifene, estrogen, and placebo on the postmenopausal endometrium. Obstet Gynecol (2000) 0.93

Usefulness of plasma phospholipid N-3 fatty acid levels in predicting dietary fish intake in patients with coronary artery disease. Am J Cardiol (1990) 0.92

A prospective study of plasma fish oil levels and incidence of myocardial infarction in U.S. male physicians. J Am Coll Cardiol (1995) 0.91

The effect of potassium supplementation in persons with a high-normal blood pressure. Results from phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Ann Epidemiol (1995) 0.90

More on chewing the fat. The good fat and the good cholesterol. N Engl J Med (1991) 0.90

Sex hormones and lipoprotein metabolism. Curr Opin Lipidol (1994) 0.90

Differential metabolism of human VLDL according to content of ApoE and ApoC-III. Arterioscler Thromb Vasc Biol (2001) 0.89

Effect of ingestion of meat on plasma cholesterol of vegetarians. JAMA (1981) 0.89

Quantitative angiographic and statistical methods to assess serial changes in coronary luminal diameter and implications for atherosclerosis regression trials. Am J Cardiol (1992) 0.89

Cholesterol and Recurrent Events: a secondary prevention trial for normolipidemic patients. CARE Investigators. Am J Cardiol (1995) 0.89

Effect of linoleic and oleic acids on blood pressure, blood viscosity, and erythrocyte cation transport. J Am Coll Nutr (1987) 0.88

Effects of a low-fat diet on plasma lipoprotein levels. Arch Intern Med (1986) 0.88

The platelet Pl(A2) and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarction. Am J Cardiol (2001) 0.87

Patterns of contagion in self-mutilation epidemics. Am J Psychiatry (1989) 0.87

Lack of an effect of dietary saturated fat and cholesterol on blood pressure in normotensives. Hypertension (1984) 0.87

Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism. J Clin Invest (1993) 0.86

Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women. J Clin Endocrinol Metab (2000) 0.86

The effects of ethanol on the clearance of estradiol in postmenopausal women. Fertil Steril (1995) 0.86

Plasma lipoprotein levels in vegetarians. The effect of ingestion of fats from dairy products. JAMA (1985) 0.86

Metabolism of Apo(a) and ApoB100 of lipoprotein(a) in women: effect of postmenopausal estrogen replacement. J Clin Endocrinol Metab (1998) 0.83

Lack of blood pressure effect with calcium and magnesium supplementation in adults with high-normal blood pressure. Results from Phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Ann Epidemiol (1995) 0.83

Comparison of excretion of nicotinuric acid after ingestion of two controlled release nicotinic acid preparations in man. J Clin Pharmacol (1988) 0.83

Adrenergic effects on plasma lipoprotein metabolism. Speculation on mechanisms of action. Am J Med (1986) 0.82

Effect of diet composition on energy expenditure during weight loss: the POUNDS LOST Study. Int J Obes (Lond) (2011) 0.81

Regulation of lipoprotein metabolism by adrenergic mechanisms. J Cardiovasc Pharmacol (1987) 0.81

Effects of shrimp consumption on plasma lipoproteins. Am J Clin Nutr (1996) 0.81

Effect of postmenopausal estrogen replacement on plasma Lp(a) lipoprotein concentrations. Arch Intern Med (1994) 0.81

Influence of baseline lipids on effectiveness of pravastatin in the CARE Trial. Cholesterol And Recurrent Events. J Am Coll Cardiol (1999) 0.81

The effect of acute ethanol ingestion on estrogen levels in postmenopausal women using transdermal estradiol. J Soc Gynecol Investig (1998) 0.81

Diet type and changes in food cravings following weight loss: findings from the POUNDS LOST Trial. Eat Weight Disord (2012) 0.81

Stability of blood pressure in vegetarians receiving dietary protein supplements. Hypertension (1984) 0.80

Self-mutilation and contagion: an empirical test. Am J Psychiatry (1985) 0.80

Natural history of coronary atherosclerosis using quantitative angiography in men, and implications for clinical trials of coronary regression. The Harvard Atherosclerosis Reversibility Project Study Group. Am J Cardiol (1993) 0.80

The effects of reproductive hormones on serum lipoproteins: unresolved issues in biology and clinical practice. Ann N Y Acad Sci (1990) 0.80

The effect of fish oil on blood pressure in mild hypertensive subjects: a randomized crossover trial. Am J Clin Nutr (1993) 0.79

Sex hormones, lipoproteins, and vascular reactivity. Curr Opin Lipidol (1995) 0.79

Effect of a modified, well-tolerated niacin regimen on serum total cholesterol, high density lipoprotein cholesterol and the cholesterol to high density lipoprotein ratio. Am J Cardiol (1989) 0.79

Effects of two types of fish oil supplements on serum lipids and plasma phospholipid fatty acids in coronary artery disease. Am J Cardiol (1990) 0.79